VYNE - VYNE Therapeutics EPS beats by $0.02 beats on revenue November, 05 2020 07:25 AM VYNE Therapeutics Inc Com VYNE Therapeutics (VYNE): Q3 Non-GAAP EPS of -$0.13 beats by $0.02; GAAP EPS of -$0.15 beats by $0.03.Revenue of $3.27M beats by $0.02M.Press Release For further details see: VYNE Therapeutics EPS beats by $0.02, beats on revenue